PMID: 6162014Jan 1, 1981Paper

The 9L rat brain tumor: description and application of an animal model

Journal of Neurology
M WeizsaeckerM Barker

Abstract

Animal models allow determination of tumor response to anticancer agents under various experimental conditions. The chemically induced 9L rat brian tumor has been developed as both in vivo and in vitro models. Animal survival, clonogenic cell survival, and tumor growth delay provide means to measure the effectiveness of treatment modalities in this tumor model. Monolayer cultures, multicellular spheroid cultures, brain tumors, and flank tumors have been used to study the influence of different biological entities of the 9L model on the response to treatment with radiation and/or BCNU (1,3-bis (2-chloroethyl)-1-nitrosourea).

References

Jan 1, 1979·International Journal of Radiation Oncology, Biology, Physics·G G Steel, M J Peckham
Sep 1, 1979·International Journal of Radiation Oncology, Biology, Physics·M BarkerD G Baker
Feb 1, 1977·Journal of Neurosurgery·M K RosenblumC B Wilson
Jan 1, 1977·International Journal of Radiation Oncology, Biology, Physics·K T WheelerS Sheppard
Apr 1, 1976·The Journal of Surgical Research·J W TaylorD W Wilmore
Jun 1, 1975·Cancer·J T LeithK T Wheeler

❮ Previous
Next ❯

Citations

Oct 6, 2006·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·George I JalloMargaret B Penno
Jan 1, 1992·Brain Research Bulletin·A GhaharyS K Malhotra
Jan 1, 1995·Journal of Photochemistry and Photobiology. B, Biology·K M HebedaH A van Alphen
Oct 22, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B D RossA Rehemtulla
Aug 8, 1998·The International Journal of Biochemistry & Cell Biology·T T WangY K Lai
Jan 20, 1996·Human Gene Therapy·A J VincentP M Hoogerbrugge
Jul 21, 1999·Journal of the National Cancer Institute·M AghiX O Breakefield
May 3, 2006·Biological & Pharmaceutical Bulletin·Seung-Hwan PaekJung-Ae Kim
Oct 1, 1984·Journal of Neurosurgery·M SalcmanE Scott
Jul 1, 1988·Journal of Neurosurgery·A H KayeM L Apuzzo
Jul 1, 1993·Journal of Neurosurgery·Y TakamiyaR L Martuza
Jul 21, 1999·Journal of Neurosurgery·O EngebraatenO Fodstad
Dec 24, 2005·Journal of Neurosurgery. Spine·Gaurav MavinkurveGeorge Jallo
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·B D RossT L Chenevert
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·A JacobsJ G Tjuvajev
Apr 21, 2009·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Ali PazirandehMaysam Zargar
Jun 1, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Laurent RisserCaroline Fonta
Mar 25, 2009·Journal of Cellular Biochemistry·Chih-Wei LoYiu-Kay Lai
Oct 20, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Irène BriggerGilles Vassal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.